Search

A recent study conducted at the Hillman Cancer Center in Pittsburgh, Pennsylvania, compared the long-term results of prostate brachytherapy with Cs-131 to stereotactic body radiotherapy data. The study included 138 patients with at least 5 years of follow-up and found that Cs-131 brachytherapy provided excellent biochemical control of prostate cancer in low and intermediate-risk patients. The research concluded that prostate brachytherapy should be considered when evaluating prostate cancer treatments in terms of patient convenience and available resources. [Extracted from the article]

A recent report from the University of Pittsburgh explores the role of Striatin-interacting protein 2 (STRIP2) in various cancers, including non-small cell lung cancer, breast cancer, colorectal cancer, and prostate cancer. The research indicates that STRIP2 is overexpressed and amplified in multiple cancer types, leading to poor prognosis. The study suggests that STRIP2 plays a critical role in oncogenic pathways such as proliferation, epithelial-mesenchymal transition, and immune regulation, highlighting its potential as a therapeutic target in cancer treatment. [Extracted from the article]

Researchers from the University of Pittsburgh conducted a study on changes in reader performance during sequential reading of digital breast tomosynthesis (DBT) screening examinations for breast cancer. The study found that radiologists showed improved recall rates and interpretation times without a change in sensitivity over the course of batch reading. The research, supported by the National Institutes of Health (NIH), analyzed data from 121,652 examinations performed between January 2018 and December 2019, involving 15 radiologists interpreting 1081 cancers. The findings suggest that readers experience perceptual adaptation when interpreting batched screening mammograms, potentially leading to improved performance. [Extracted from the article]

The University of Pittsburgh researchers conducted a study on factors influencing the placebo response rate in randomized controlled trials of antiseizure medications for focal epilepsy. The study found that higher placebo responder rates were associated with markers of less-refractory epilepsy, such as shorter duration of epilepsy, lower baseline seizure rate, and fewer concomitant antiseizure medications. Additionally, there were significant differences in placebo responder rates by country and geographic region, with countries like Bulgaria, Croatia, India, and Canada showing higher rates. This research provides valuable insights for future clinical trials in estimating placebo responder rates and improving power estimates. [Extracted from the article]

A study conducted at the University of Pittsburgh focused on the use of robotic-assisted median arcuate ligament release prior to pancreatoduodenectomy to address celiac artery stenosis. This technique has shown a nearly 90% success rate in resolving ischemic complications and preventing postoperative hepatic ischemia and pancreatic fistulae. The research emphasizes the importance of preoperative management of stenosis to avoid complications during surgery, highlighting the effectiveness and safety of this approach in decompressing celiac axis stenosis. [Extracted from the article]

Researchers from the University of Pittsburgh have published new data on Hereditary Hemorrhagic Telangiectasia (HHT) in a pediatric-focused review. HHT is characterized by vascular malformations in various organs, leading to bleeding and other complications. While there is no cure for HHT, medical management options include oral tranexamic acid and IV bevacizumab, with endovascular and surgical treatments considered when benefits outweigh risks. This research has been peer-reviewed and provides valuable insights into the diagnosis and management of HHT in pediatric patients. [Extracted from the article]

A study conducted at Carnegie Mellon University in Pittsburgh, Pennsylvania, explores the impact of age-related extracellular matrix stiffness on muscle stem cell differentiation. The research reveals that stiffening of the ECM with age hinders muscle regeneration by causing dysfunction in muscle stem cells. The study identifies the activation of the TNF-related apoptosis-inducing ligand (TRAIL) pathway as a significant factor in aged cells cultured on stiff substrates, leading to age-related declines in muscle function through inflammatory and apoptotic mediators. This peer-reviewed research sheds light on the complex mechanisms underlying age-related changes in muscle stem cell differentiation. [Extracted from the article]

Researchers from the University of Pittsburgh have conducted studies on Carbapenem-resistant Acinetobacter baumannii infections, a bacterium associated with high mortality rates and resistance to most antibiotics. The research highlights the lack of global consensus on treatment strategies due to the diversity of current clinical practices and the scarcity of large-scale controlled studies. Emerging treatment options such as cefiderocol and sulbactam-durlobactam show promise, but further clinical validation is needed. This peer-reviewed research provides insights into new therapeutic modalities for addressing this challenging pathogen. [Extracted from the article]

A recent study from the University of Pittsburgh explores the relationship between emotion differentiation and social anxiety disorder (SAD) in adolescent girls at high risk for SAD. The research suggests that negative emotion differentiation may act as a protective factor against intergenerational risk for social anxiety. Findings highlight the importance of emotion differentiation in understanding and treating SAD, particularly in adolescent girls. The study was supported by the NIH National Institute of Mental Health (NIMH) and has been peer-reviewed. [Extracted from the article]

A study conducted at the University of Pittsburgh focused on changes in pain quality and biomarkers in patients with chronic pancreatitis. The study found that while some patients experienced changes in pain phenotype at the one-year follow-up, the biomarker GP130 remained consistent for mixed-type pain in chronic pancreatitis. The research suggests that targeting certain biomarkers like GP130 could be a potential therapeutic target for managing chronic pancreatitis pain. The study was funded by NIH and published in Pancreatology. [Extracted from the article]

Researchers from the University of Pittsburgh conducted a systematic review on the costs of drug-associated acute kidney injury (D-AKI) and potential cost savings with nephrotoxin stewardship strategies. The study found that the economic burden of D-AKI is significant, with total admission costs ranging from $47,696 to $173,569 for patients who developed D-AKI. Implementing nephrotoxin stewardship programs, such as substituting less nephrotoxic drugs or using therapeutic drug monitoring, can lead to total medical cost savings ranging from $5,171 to $364,973. The research emphasizes the importance of adopting efficient nephrotoxin stewardship programs to optimize patient care and reduce costs. [Extracted from the article]

A recent study conducted at the University of Pittsburgh focused on the diagnostic challenges posed by low-level mdm2 amplification in certain tumors. The study compared fluorescence in situ hybridization (FISH) results with next-generation sequencing (NGS) assay results to determine the accuracy of mdm2 amplification status. The research found that in cases of 'low-level' mdm2 amplification, NGS assay results contradicted FISH results, indicating a need for caution in diagnosis and treatment decisions. Further studies are recommended to better understand and address these diagnostic dilemmas. [Extracted from the article]

A recent study conducted at the University of Pittsburgh focused on the metabolic regulation of glioblastoma stem cells (GSCs) by malate dehydrogenase 2 (MDH2). The research found that targeting MDH2 could attenuate GSC proliferation and in vivo tumor growth, with potential therapeutic implications. This peer-reviewed study sheds light on how stem-like tumor cells alter their metabolism to impact their epitranscriptomes, offering new avenues for treatment. [Extracted from the article]

A study conducted at the University of Pittsburgh examined the impact of chronic obstructive pulmonary disease (COPD) or emphysema on patients with acute respiratory distress syndrome (ARDS). The research found that patients with COPD/emphysema had similar clinical outcomes and biomarker profiles compared to those without COPD/emphysema, but had a shorter duration of mechanical ventilation and ICU stay. The study suggests that future research should focus on differences in responses based on disease severity and explore targeted therapeutic strategies for ARDS patients with COPD or emphysema. [Extracted from the article]

A recent report from the University of Pittsburgh discusses the complexities of Metastatic Breast Cancer (MBC) and its impact on end-of-life care. The research highlights the challenges faced by healthcare providers in determining when treatments are no longer beneficial and may lead to poor quality end-of-life experiences. The study emphasizes the importance of tailored and precise care to prevent prolonged, inappropriate, and costly treatments for patients with MBC. For more information, the Journal of Hospice and Palliative Nursing can be contacted directly. [Extracted from the article]

A recent study from the University of Pittsburgh explores the use of 3D printing technology to manufacture vaginal films containing metronidazole for the treatment of Bacterial Vaginosis (BV). The research aims to address issues with existing dosage forms, such as leakage and reduced patient adherence. The study demonstrates the feasibility of 3D printing as an effective method for producing metronidazole-loaded vaginal films with precise dosing and improved bioretention, offering a promising alternative for BV treatment. The findings highlight the potential benefits of this innovative approach in women's health care. [Extracted from the article]

Researchers at Magee Women's Research Institute in Pittsburgh, Pennsylvania, have identified Egfl6 as a key regulator of myeloid cell functions in ovarian cancer. Their study found that Egfl6 promotes the immunosuppressive functions of tumor-associated myeloid cells, leading to resistance to immunotherapy. The research suggests that targeting Egfl6 could enhance immunotherapy in patients with ovarian cancer. For more information, readers can refer to the Journal of Clinical Investigation. [Extracted from the article]

Researchers at the University of Pittsburgh have found that platelet aggregation plays a crucial role in the formation of cerebral aneurysms. By targeting platelet aggregation and downstream inflammation, they were able to prevent aneurysm formation and progression in mice. The study suggests that small molecule inhibitors could be used to prevent cerebral aneurysm formation or progression, offering potential new avenues for treatment. The research was supported by the Brain Aneurysm Foundation and has been peer-reviewed, providing valuable insights into cardiovascular diseases and conditions. [Extracted from the article]

A recent study conducted by the University of Pittsburgh compared liberal and restrictive transfusion strategies in patients with acute myocardial infarction-associated anemia. The meta-analysis involving 4,217 participants found no statistically significant differences in all-cause mortality or major outcomes between the two strategies within 30 days. The researchers concluded that the observed heterogeneity in blood use likely explains the variable findings across randomized controlled trials. [Extracted from the article]

Researchers at the University of Pittsburgh have found that myoglobin, a heme protein expressed in breast tumors, inhibits breast cancer cell migration and fatty acid oxidation through heme-dependent oxidant production, not fatty acid binding. This study, supported by the National Institutes of Health and the Hemophilia Center of Western Pennsylvania, sheds light on the molecular mechanisms underlying myoglobin's impact on breast cancer prognosis. The findings suggest potential therapeutic strategies to target oxidant production and myoglobin in breast cancer treatment. [Extracted from the article]

A recent study conducted at Magee-Women's Hospital in Pittsburgh, Pennsylvania, explored the importance of surgical margins in patients undergoing neoadjuvant radiation for vulvar cancer. The study found that a complete pathologic response improved overall survival and disease-free survival compared to residual disease. Factors such as depth of invasion and lymphovascular space invasion significantly impacted outcomes, with a depth of invasion greater than 9 mm showing decreased overall survival. The research concluded that response to radiation, rather than margin status, drove survival and recurrence in this cohort. [Extracted from the article]

A recent study conducted by the University of Pittsburgh focused on the predictive capabilities of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) measurements in patients with hemorrhagic shock and traumatic brain injury (TBI). The research found that early elevated GFAP measurements were associated with worse head CT scan Rotterdam scores, TBI progression, and worse Glasgow Outcome Scale-Extended (GOSE) scores, independent of other injury attributes, shock severity, and early resuscitation characteristics. The study highlights the potential of early measurements of GFAP and UCH-L1 on a point-of-care device to predict CT-diagnosed TBI in patients with polytrauma and shock. [Extracted from the article]

A recent study conducted by researchers at the University of Rochester focused on identifying clusters of severe maternal morbidity (SMM) using a data-driven approach. The study analyzed 97,492 deliveries and identified four distinct SMM clusters: Hemorrhage, Critical Care, Vascular, and Shock. These clusters were associated with different maternal and neonatal outcomes, highlighting the importance of understanding the underlying pathways and comorbidities that contribute to SMM. The research, which has been peer-reviewed, provides valuable insights into the complex nature of SMM and its risk factors. [Extracted from the article]

Researchers at the University of Pittsburgh have conducted a study on human-induced pluripotent stem cells to model the effects of the TM6SF2-E167K mutation associated with liver disease. The study revealed decreased TM6SF2 protein expression, increased intracellular lipid droplets, and changes in gene expression related to lipid metabolism. This in vitro model could potentially identify clinical targets and therapeutic strategies for addressing the impact of this mutation on hepatic lipid metabolism. The study was supported by the National Institutes of Health and has been peer-reviewed. [Extracted from the article]

A study conducted at the University of Pittsburgh examined the role of adjuvant chemotherapy in patients with locally advanced rectal cancer who underwent neoadjuvant chemoradiation followed by proctectomy. The research found that adjuvant chemotherapy was associated with lower mortality and locoregional recurrence rates, particularly in patients with complete total mesorectal excision. The study concluded that adjuvant chemotherapy may lead to positive outcomes in these patients. For more information, the full article can be found in the Journal of Surgical Research. [Extracted from the article]

Researchers at the University of Pittsburgh have conducted a study on therapeutic plasma exchange to reverse plasma failure in multiple organ dysfunction syndrome. The study highlights the importance of maintaining a well-functioning plasma regulatory milieu to control coagulation and inflammation. Therapeutic plasma exchange is identified as a unique method to remove harmful factors and replete exhausted components, restoring appropriate regulation of coagulation and inflammation. The research was supported by the NIH National Institute of General Medical Sciences and has been peer-reviewed for publication in the Journal of Clinical Apheresis. [Extracted from the article]

A recent report from the University of Pittsburgh discusses the importance of biomarkers in clinical trials for Alzheimer's disease. The research highlights the role of biomarkers in population selection and disease monitoring, particularly in trials for drugs targeting amyloid-(3. The study emphasizes the growing significance of biomarkers in drug development and explores various applications of biomarkers in Alzheimer's disease research. For more information, the full report can be found in EBioMedicine, with contact information available for the researchers involved. [Extracted from the article]

Researchers from the University of Pittsburgh have conducted a study on the role of Mdia2 in regulating breast cancer cell migration. The study found that increased MRTF-A activity is associated with more effective cell migration and membrane protrusion. The research suggests a potential for developing specific small molecule inhibitors targeting the MRTF-SRF transcriptional complex as therapeutic agents for breast cancer. This study has been peer-reviewed and provides valuable insights into the mechanisms underlying breast cancer cell migration. [Extracted from the article]

A recent study conducted at the University of Pittsburgh explores the role of the metabolic enzyme ACSS2 in driving quiescence in ovarian cancer cells. The research suggests that increased ACSS2 activity leads to a reversible cell cycle exit in ovarian cancer cells, potentially impacting therapeutic response to chemotherapies like platinum. The study highlights the importance of metabolic reprogramming in understanding ovarian cancer progression and treatment outcomes. [Extracted from the article]

Research conducted at Allegheny Health Network has provided new information about venous thromboembolism in transgender patients undergoing gender-affirming hormone therapy through mid-life. The study highlights the lack of formal recommendations or guidance on the continuation of hormone therapy into mid-life for transgender individuals. While there are risks associated with hormone therapy, further research is needed to better understand the potential cardiovascular and bone health implications for transgender patients. The study emphasizes the importance of counseling, monitoring, and prevention strategies for transgender individuals undergoing hormone therapy. [Extracted from the article]

Researchers at the University of Pittsburgh have developed a liposomal formulation for delivering PARP inhibitors (PARPi) and 2-hydroxyglutarate (2HG) to target DNA repair in cancer cells. This approach aims to enhance the effectiveness of PARPi in both HR-deficient and HR-proficient tumors by synergistically enhancing DNA repair defects. The study also found that the combination of veliparib and 2HG via liposomal co-delivery can activate the STING pathway and downregulate PD-L1 expression, potentially augmenting the function of cytotoxic T cells. The research was supported by the National Institutes of Health (NIH) and has been peer-reviewed. [Extracted from the article]

A recent study published in Gastroenterology Week discusses complications after paraesophageal hernia repair, emphasizing the importance of early detection and repair to improve long-term outcomes. The research highlights the need for comprehensive assessment of patient-specific risks for proper perioperative planning. The study, conducted by researchers at the Surgical Institute in Pittsburgh, Pennsylvania, underscores the technical nature of paraesophageal hernia repair and its impact on foregut physiology. [Extracted from the article]

Researchers at Allegheny Health Network conducted a study on the impact of palliative care consultations for patients with liver disease, specifically cirrhosis. They found that only about 1 in 10 cirrhotic patients received a palliative care consultation, with older patients, males, and those diagnosed with hepatocellular carcinoma being more likely to receive this care. The study highlights the importance of considering palliative care for patients with liver disease. [Extracted from the article]

Researchers at Hillman Cancer Center in Pittsburgh, Pennsylvania, have developed a method using liquid chromatography-mass spectrometry to quantify the DNA-dependent protein kinase inhibitor Peposertib (M3814) and its metabolite in human plasma. This inhibitor is crucial for DNA repair and cell survival, particularly in cancer treatment. The research, supported by Merck KGaA, aims to define the pharmacokinetics of Peposertib through ongoing clinical studies. The study has been peer-reviewed and published in Biomedical Chromatography, providing valuable insights for future cancer therapies. [Extracted from the article]